Swiss National Bank’s Cardlytics CDLX Stock Holding History

Swiss National Bank’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,090	Closed	-$468K	–	2647
2022 Q4	$468K	Hold	8,090	–	–	﹤0.01%	2585
2022 Q3	$760K	Buy	8,090 +220	+3%	+$31.3K	﹤0.01%	2444
2022 Q2	$1.76M	Hold	7,870	–	–	﹤0.01%	2014
2022 Q1	$4.33M	Buy	7,870 +600	+8%	+$363K	﹤0.01%	1534
2021 Q4	$4.8M	Hold	7,270	–	–	﹤0.01%	1489
2021 Q3	$6.1M	Buy	7,270 +270	+4%	+$274K	﹤0.01%	1323
2021 Q2	$8.88M	Sell	7,000 -230	-3%	-$260K	0.01%	1080
2021 Q1	$7.93M	Buy	7,230 +1,680	+30%	+$2.22M	0.01%	1144
2020 Q4	$7.92M	Buy	5,550 +50	+0.9%	+$53.3K	0.01%	1069
2020 Q3	$3.88M	Buy	5,500 +330	+6%	+$240K	﹤0.01%	1334
2020 Q2	$3.62M	Buy	5,170 +1,180	+30%	+$681K	﹤0.01%	1336
2020 Q1	$1.4M	Buy	3,990 +270	+7%	+$191K	﹤0.01%	1659
2019 Q4	$2.34M	Buy	+3,720	New	+$1.82M	﹤0.01%	1643

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GEH

General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

Swiss National Bank's CDLX Position: Q1 2023 in Review

Swiss National Bank sold out of Cardlytics (CDLX) in Q1 2023, closing a stake of 8,090 shares — an estimated $468K sold.

Swiss National Bank first reported a position in CDLX in Q4 2019 and held it in 13 quarters. The position peaked at $8.88M in Q2 2021. 103 funds tracked by Wall St. Rank hold CDLX as of Q1 2023.

Swiss National Bank reported no remaining Cardlytics position as of Q1 2023 after selling out during the quarter.
Swiss National Bank sold 8,090 Cardlytics shares in Q1 2023, an estimated $468K.
Swiss National Bank first reported a position in Cardlytics in Q4 2019 and held it in 13 quarters.
Swiss National Bank's Cardlytics position peaked at $8.88M in Q2 2021.
103 funds tracked by Wall St. Rank held Cardlytics as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.